Results 161 to 170 of about 238,767 (310)
Interaction between toll-like receptor 4 polymorphism and abdominal obesity on ovarian cancer risk in Chinese women. [PDF]
Zhu J +5 more
europepmc +1 more source
Preparation of a biopolymer‐based immune implant (BI) for the sustained release of R848 and oxaliplatin (OXA), enabling immune activation and preventing recurrence after radiofrequency ablation (RFA) treatment in hepatocellular carcinoma (HCC). Abstract Hepatocellular carcinoma (HCC) remains a global challenge due to limited therapies and high ...
Yuezhan Shan +9 more
wiley +1 more source
Toll-like receptor-mediated immune imbalance in asthma: controversies, breakthroughs, and future directions. [PDF]
Xu X, Yu R, Yang Z, Li C, Xiong H, Li C.
europepmc +1 more source
SETComp, a transfer learning model based on permutation‐invariance, is pre‐trained on single‐compound intervention data and fine‐tuned on complex system (e.g., natural products) data. The model achieves up to 93.86% accuracy on complex system‐cell‐gene association predictions, outperforming the baseline by up to 27.59%.
Boyang Wang +4 more
wiley +1 more source
Toll-like receptor 3: a double-edged sword. [PDF]
Hsieh ML +4 more
europepmc +1 more source
Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens [PDF]
Norimitsu Kadowaki +6 more
openalex +1 more source
In superficial second‐degree burn wounds, Gb3 turns on genes related to papillary cells through the FGF2 signaling pathway. This increases the ability of cells to break down fibrin and decreases fibrosis, which ultimately prevents scar formation in burn injuries.
Sujie Xie +13 more
wiley +1 more source
Urothelial collective-gliding response acts as a toll-like receptor 4-associated defense mechanism. [PDF]
Zhang N +17 more
europepmc +1 more source
Endocytosed HSP60s Use Toll-like Receptor 2 (TLR2) and TLR4 to Activate the Toll/Interleukin-1 Receptor Signaling Pathway in Innate Immune Cells [PDF]
R. Martin Vabulas +6 more
openalex +1 more source

